** Shares of Emyria Ltd EMD.AX rise 32% to A$0.033, their highest since May 22
** The early-stage drug developer announces multi-year agreement with Medibank MPL.AX wherein the latter's customers can access EMD's s Empax PTSD care program
** EMD also raises A$4 million ($2.59 million) at A$0.024, a discount of 4% to the stock's last close
** Says proceeds will be used for programs under the Medibank agreement among others
** Stock set for best day since March 7, if gains hold
** Stock sees busiest session in over two years, as 12 mln shares change hands, 18.1x the 30-day average of 663,166
** MPL up 1.2% to A$4.96 for the session
** EMD down 2.9% YTD, including moves in current session
($1 = 1.5423 Australian dollars)
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。